Biology subjects

Sallese, M. R.

Publications and source records attributed to Sallese, M. R..

4 recordsLinked to original sources

bioRxiv2026

Fine-Grained and Reliable Cell Classification from Pathology Images

Molecular assays such as spatial transcriptomics facilitate fine-grained identification of cell types for analyzing tumor microenvironments. However, they are expensive to acquire in routine clinical practice compared to hematoxylin and eosin (H&E) images. With molecular guidance, such images can distinguish cell lineages, yet often fail to resolve closely related subtypes. To overcome this, we introduce CellBridge, a multi-modal contrastive learning framework pretrained on 16M cells with paired H&E and spatial profiles, for transferring molecular information into morphological representations. CellBridge further incorporates a Cell-Ontology-aware conformal prediction module that assigns labels at different levels of specificity: leaf-level cell types when morphology alone provides sufficient evidence, and broader ancestor categories when distinguishing among more specific cell types would require molecular information. Across in-domain and out-of-domain benchmarks, CellBridge outperforms leading pathology foundation models in macro F1 by up to 16 percentage points, with the largest gains on the most fine-grained label spaces. It consistently achieves smaller prediction sets, while reducing class-wise coverage gaps. We envision CellBridge as a step toward extracting cellular information that currently requires costly molecular assays from routinely acquired pathology images, while explicitly identifying where such assays remain necessary. Our code is available at https://github.com/Lotfollahi-lab/cellbridge.

bioinformatics↗

bioRxiv2026

Multi-scale modeling of human tissues from spatial transcriptomics with TERRA

Spatial transcriptomics maps gene expression at cellular resolution, revealing how cells organize into multicellular niches. Yet computational analyses remain dataset-specific, without a transferable representation of tissue organization that generalizes across datasets, tasks and tissues or predicts how tissues behave under perturbation. We present TERRA, a foundation model pretrained on 112 million human cells profiled by spatial transcriptomics. From a single pretrained backbone, TERRA yields embeddings at the scale of cells, the genes they express and the neighborhoods in which they reside, and supports spatial in silico perturbation, all applied zero-shot to unseen tissues. At the cell level, in newly generated spatial data for developing pancreas, TERRA identified an islet-associated capillary state which we posit represents a developmental precursor of the mature islet microvasculature. At the gene level, in untreated kidney sections, in silico knockout of immune-checkpoint targets predicted a gene program of immune-checkpoint-blockade-associated nephrotoxicity, which we validated in treatment-exposed tissue and recovered in blood. At the neighborhood level, TERRA mapped macrophages across tissues to identify recurring cross-organ niches, which we term archetypes, including a tumor-boundary niche associated with poor prognosis in kidney cancer. Together, TERRA captures the spatial and multicellular logic of human tissue and predicts, in silico, its response to perturbation, providing a multi-scale framework for tissue biology, therapeutic development and clinical application.

genomics↗

bioRxiv2025

Mapping and reprogramming microenvironment-induced cell states in human disease using generative AI

Tissue microenvironments reprogram local cellular states in disease, yet current computational spatial methods remain descriptive and do not simulate tissue perturbation. We present MintFlow, a generative AI algorithm that learns how the tissue microenvironment influences cell states and predicts how tissue perturbations can reprogram them. Applied to three human diseases, MintFlow uncovered distinct pathogenic spatial reprogramming in inflammatory and tumor microenvironments. In atopic dermatitis, MintFlow identified a novel, spatially-imprinted, type 2 (IL13+ITGAE+) epidermal T resident memory cell population (type 2 TRM), and decoded signaling pathways within the perivascular lymphoid niche. In melanoma, MintFlow identified fibrotic stroma resembling keloid scar tissue. In kidney cancer, MintFlow resolved immunosuppressed CD8+ T cell states within tertiary lymphoid structures. Furthermore, MintFlow enabled in silico perturbations of disease-relevant cell states and tissue environments. Regulatory T cell modulation in atopic dermatitis was predicted to suppress the pro-inflammatory tissue environment, supporting manipulation of these cells as a therapeutic target. In kidney cancer, in silico T cell replacement recapitulated immune checkpoint blockade, while spatially targeted macrophage depletion reverted immunosuppressed T cell states. The corresponding gene programs correlated with survival in large kidney cancer patient cohorts. Together, these findings position MintFlow as a tool for unbiased disease mechanism prediction and in silico perturbation, accelerating translational hypothesis generation and guiding therapeutic strategies.

genomics↗

bioRxiv2025

A harmonized ovarian cancer scRNA-seq atlas to dissect disease heterogeneity underlying metastatization and chemoresistance

The advent of single cell technology has enabled researchers with the ability to achieve unprecedented resolution in the characterization of biological systems. The consequent increasing availability of single cell dataset brought about the possibility to obtain comprehensive reference atlases, to shed light on the molecular and cellular foundations of healthy and diseased tissues. This process has highlighted the need to integrate datasets from different sources while being able to distinguish true biological signal from technical confounders. While this issue is widespread to most biological settings, it holds especially true for cancer samples, which are characterized by a diffused inter- and intra-patient phenotypic heterogeneity. To address this issue, here we developed a novel integration method tailored to highly heterogeneous single cell transcriptomic data and applied it to one of the quintessential heterogeneous cancer type, namely high-grade serous ovarian cancer, to generate the first reference atlas for this disease. By identifying patient-specific cell populations and deriving metacells, we were able to preserve inter-patient biological variability. Using a variational autoencoder, we integrated metacell data, revealing an evolving landscape of cell states along disease progression and treatment for each of the main cell types constituting the dataset. Also, we showed the potential of this resource by identifying diffused and tissue/treatment-specific cell-to-cell interactions. Finally, the generated integration model allowed to expand the atlas with additional data, granting iterative refinement over time of this disease reference. Our strategy now provides a valuable resource for the cancer research community, facilitating the investigation of tumor heterogeneity towards the development of novel therapeutic strategies.

cancer biology↗